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Obesity is an epidemic that continues to grow unabated in devel-
oped nations where an abundance of calorically dense foods are 
plentiful and easily obtained. This excess of food is a major con-
tributor to high levels of obesity, which is a major risk factor 
for cardiovascular disease, certain types of cancer, and type 2 
diabetes. Through neuroscience research, critical contributions 
can be made in developing an understanding of the mechanisms 
underlying this problem, ultimately leading to treatment of this 
escalating disorder (1).
Agouti-related protein (AgRP) neurons are located in the arcu-
ate nucleus (ARC) of the hypothalamus and have been impli-
cated in regulating energy homeostasis (2). They release AgRP, 
neuropeptide Y (NPY) and γ-aminobutyric acid (GABA), all of 
which have been linked with changes in energy balance (2–5). 
Despite evidence for their involvement in feeding behavior and 
energy balance, the exact contribution of these neurons remains 
unclear, since chronic and acute perturbations of AgRP neurons 
and the factors they release have produced inconsistent results. 
Overexpression of AgRP in transgenic mice produces obesity, 
and central administration of the orexigenic peptides, AgRP or 
NPY, causes hyperphagia (2, 3). However, targeted deletion of the 
genes encoding AgRP, NPY, and/or vesicular GABA transporter 
(VGAT; required for release of GABA) has minimal effects on feed-
ing (4–6). Likewise, acute ablation of AgRP neurons in neonates 
or delayed degeneration of AgRP neurons during adulthood has 
little impact on energy metabolism (7–9). Conversely, acute abla-
tion of AgRP neurons in adult mice, a manipulation associated 
with gliosis (5), induces severe hypophagia (7, 8). Given the above, 
manipulating AgRP neurons in a manner that is selective, rapid, 
and reversible, should provide insight, both qualitative and quan-
titative, into the function of these neurons.
Results and Discussion
One way to accomplish this is via designer receptors exclusively 
activated by designer drugs (DREADD) technology, in which 
muscarinic GPCRs are mutated so that their ability to bind 
natural ligands is lost, while nanomolar potency is gained for 
the otherwise pharmacologically inert ligand clozapine-N-oxide 
(CNO) (10, 11). The stimulatory DREADD, designated “hM3Dq”, 
couples through the Gq pathway to depolarize neurons (10, 11). 
Here, we used a Cre-recombinase–dependent adeno-associated 
virus (AAV) to target hM3Dq to AgRP neurons (Figure 1A). The 
DREADD was fused to mCherry so that receptor expression could 
be monitored. Stable transgene inversion was achieved using the 
FLEX Switch (12). When the AAV-hM3Dq-mCherry was stereo-
taxically injected into the ARC of AgRP-Ires-cre mice, mCherry was 
detected exclusively in the ARC, in a pattern consistent with AgRP 
neurons (Figure 1B). Importantly, no expression was detected fol-
lowing injection into non–Cre-expressing mice (data not shown). 
Furthermore, mCherry was restricted to AgRP–Cre-expressing 
cells, as revealed by colocalization with GFP in mice also harbor-
ing a Cre-dependent GFP reporter transgene (Figure 1C) (>95% of 
GFP-expressing neurons express mCherry). Notably, GFP protein 
is cytoplasmic, while the DREADD receptor is expressed on the 
plasma membrane. Whole cell, current clamp recordings were then 
performed in mCherry-expressing AgRP neurons. When added to 
the brain slice, CNO depolarized and markedly increased the fir-
ing rate of AgRP neurons (Figure 1D). The effect of CNO-induced 
depolarization was reversible following washout (Figure 1D). 
Importantly, CNO did not affect the membrane potential of non–
DREADD-expressing AgRP neurons (data not shown). When 
injected in vivo, CNO greatly increased c-fos immunoreactivity 
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in the ARC in a pattern consistent with AgRP-expressing neurons 
(Figure 1E), further evidence that this approach acutely and spe-
cifically stimulates neuronal activity.
One critical advantage of this approach, as it applies to investi-
gating in vivo behavior, is that the same animal can be used as its 
own control (e.g., saline versus CNO). As an additional control, 
we also injected wild-type littermate animals with AAV-hM3Dq-
mCherry virus into the ARC. Thus, all mice shown in Figures 2 and 3 
had received bilateral injections of AAV-DREADD-mCherry. 
However, only the AgRP-Ires-cre mice expressed DREADD in 
AgRP neurons. Stimulation of AgRP neurons via i.p. injection 
of CNO (0.3 mg/kg) rapidly (in a matter of minutes) induced 
feeding (see Supplemental Video 1; supplemental material avail-
able online with this article; doi:10.1172/JCI46229DS1). Mice 
fed ad lib were injected during the light phase, a time in which 
mice normally refrain from eating. CNO-injected AgRP-Ires-cre 
mice ate nearly 4-fold more than controls in the first 30 min-
utes after injection and continued to eat at a higher rate for the 
duration of the study (Figure 2A). Furthermore, stimulation of 
AgRP neurons produced a sharp decline in energy expenditure 
(Figure 2B), which lasted for approximately 8 hours. Notably, 
this duration of action for a single injection of CNO is consis-
tent with a previous report (11).
Chronic stimulation of AgRP neurons via twice-daily injec-
tions of CNO caused marked weight gain (Figure 2C). AgRP-
Ires-cre mice injected with CNO gained 2.5 g following 1 day of 
treatment and continued to amass weight at a reduced rate until 
CNO injections were stopped on day 11 (after 5 days of CNO), 
at which point the AgRP-Ires-cre mice had gained 4.6 g of body 
weight (Figure 2C), including 2.9 g of fat (Figure 2D). This sub-
stantial weight gain was due to increased food intake (Figure 2E) 
and, most likely, also decreased energy expenditure (Figure 2B). 
Of interest, the CNO-induced obesity was completely reversed 
following 5 days of drug withdrawal (Figure 2, C and D), and this 
reversal was associated with hypophagia (Figure 2E). Complete 
normalization of body weight and adiposity, caused in part by 
“compensatory” hypophagia, strongly supports the existence of 
a set point for these parameters (13).
The above studies strongly support the sufficiency of AgRP neu-
rons to promote body weight gain via increases in food intake 
and decreases in energy expenditure. To further address whether 
these same neurons are required for feeding behavior, we used an 
identical viral approach in which we subsequently expressed the 
Gi/o-coupled inhibitory DREADD, designated “hM4Di”, in AgRP 
neurons (10, 11, 14). As assessed by whole cell, current clamp 
recordings, CNO both hyperpolarized and decreased the firing 
Figure 1
Cre-dependent AAV-hM3Dq-mCherry is specifically expressed in the ARC of AgRP-Ires-cre mice and confers activation by CNO. (A) Design 
of hM3Dq-mCherry AAV employing the FLEX Switch strategy, which uses 2 pairs of heterotypic, antiparallel loxP-type recombination sites 
to achieve Cre-mediated transgene inversion and expression (12). L-ITR, left-inverted terminal repeat; R-ITR, right-inverted terminal repeat; 
WPRE, woodchuck hepatitis posttranscriptional regulatory element. (B) Top: Schematic indicating the site of the imaged area in the ARC of the 
hypothalamus. Bottom: mCherry fluorescence exclusively in the ARC after bilateral injections of AAV-hM3Dq-mCherry into the hypothalamus 
of AgRP-Ires-cre mice crossed with Z/EG Cre-dependent reporter mice. Z/EG mice expressed GFP protein following Cre-mediated excision 
of an intervening sequence (Scale bar: 100 μm). (C) Colocalization of mCherry (anti-dsRed) and anti-GFP fluorescence in the ARC. Note that 
GFP is cytoplasmic and DREADD is expressed on the plasma membrane (scale bar: 10 μm). (D) Whole cell, current clamp recording from an 
AgRP neuron marked by mCherry fluorescence from an AgRP-Ires-cre mouse injected with AAV-hM3Dq-mCherry. CNO (5 μM) elicited rapid 
depolarization of the membrane potential and greatly increased the firing rate. This example trace is representative of 4 similar recordings. (E) 
Injection of CNO in vivo induces c-fos immunoreactivity in the ARC. Brains were obtained for c-fos analysis 90 minutes following injection of 
saline or CNO (0.3 mg/kg of body weight, i.p.) (scale bars: 120 μm).
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rate of hM4Di-expressing AgRP neurons (Figure 2F). Notably, 
inhibition of AgRP neurons in vivo at the onset of the dark cycle 
(when the majority of food intake normally occurs) significantly 
reduced food intake (Figure 2G).
It has been suggested that the hypothalamic neurocircuitry 
responsible for integrating metabolic signals is embedded within 
a complex network that permits both the adaptation and syn-
chronization of nutrient needs to conditions in the animal’s local 
environment (15). It is likely that these same neurons invoke neu-
ral mechanisms of reward, motivation, and decision making, all of 
which are integrated to serve the ultimate goal of obtaining and 
ingesting food. To determine whether these more complex aspects 
of feeding behavior are engaged by basal hypothalamic neurons, 
we stimulated AgRP neurons in mice fed ad lib and then assessed 
their motivation to work (e.g., via a nose poke beam-break setup) 
for food reinforcements using a progressive ratio operant condi-
Figure 2
Manipulation of AgRP neuron activity alters energy balance. (A) Food intake. CNO (0.3 mg/kg of body weight, i.p.) or saline was injected 3 hours 
after the start of the 12-hour light cycle, and food intake was assessed between 30 minutes and 4 hours after injection (PI). Data are from male 
mice (mean ± SEM, n = 12; *P < 0.01). AgRP-i-Cre, AgRP-Ires-cre mice. (B) Oxygen consumption. Mice were acclimated in metabolic cages 
and injected with either saline (blunted arrow) or CNO (arrow) at 8:30 am. Black bars along the x axis indicate the 12-hour dark cycle. Data are 
from male mice (mean ± SEM, n = 6; *P < 0.01). (C–E) Chronic stimulation of AgRP neurons. (C) Body weight, (D) fat mass, and (E) food intake. 
AgRP-Ires-cre and wild-type control mice were injected twice daily (at 9:00 am and 5:00 pm) with saline from days 1–5, CNO (0.3 mg/kg of body 
weight, i.p.) from days 6–10 (arrow), and saline from days 11–15 (blunted arrow). Data are from female mice (mean ± SEM, n = 12; *P < 0.01). 
(F and G) Inhibitory DREADD (hM4Di). (F) Whole cell, current clamp recording from an AgRP neuron marked by mCherry fluorescence from a 
AgRP-Ires-cre mouse injected with AAV-hM4Di-mCherry. CNO (10 μM) hyperpolarized the membrane potential and decreased the firing rate. 
This example trace is representative of 5 similar recordings. (G) Inhibition of AgRP neurons decreases food intake. CNO (0.3 mg/kg of body 
weight, i.p.) or saline was injected at the start of the 12-hour dark cycle, and food intake was assessed between 30 minutes and 4 hours PI. Data 
are from male mice (mean ± SEM, n = 6; *P < 0.05).
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tioning paradigm (16). In this assay, an animal’s willingness to 
work for food is represented by its breakpoint, the highest number 
of successive nose pokes a mouse will perform, in a progressively 
increasing paradigm (i.e., 1, 4, 7), to procure a single food pellet. 
For these operant conditioning studies, all mice were trained in the 
absence of CNO on a fixed ratio of 1 (FR1: 1 nose poke/1 pellet) 
for 5 consecutive days to learn to correctly associate a nose poke 
with the delivery of food reinforcement. The motivation to obtain 
food reinforcement was then assessed using a progressive ratio 
of 3 (PR3). When AgRP neurons were activated by CNO, mice 
reached a dramatically higher breakpoint (Figure 3A), which was 
similar in magnitude to that induced by the calorically deficient, 
fasted state (Figure 3A). Thus, even in a calorically replete state, 
stimulation of AgRP neurons alone can drive intense motivated 
behavior for food reinforcement.
To further investigate goal-directed behavior aimed at food acqui-
sition, we measured physical activity (17) in AgRP-Ires-cre and wild-
type mice fed ad lib and injected with either saline or CNO during 
the light cycle. In the first trial, food was removed simultaneously 
with administration of CNO or saline; in the second trial, food was 
freely available. Stimulating AgRP neurons in the absence of food 
led to intense, unrelenting activity, a behavioral state that contin-
ued unabated for hours (Figure 3B). We interpreted this as food-
seeking behavior because the mice were often seen visiting areas of 
the cage where food was normally located and were also engaging in 
vigorous digging-type behaviors (see Supplemental Video 2). When 
the same mice were again given CNO on a different day, this time in 
the presence of food, this sharp increase in activity was completely 
absent (Figure 3B), indicating that the marked activity was directed 
toward the acquisition and consumption of food.
Cre-dependent AAV-DREADDs, in combination with neuron-
specific cre mice, provide a technically easy means of rapidly, spe-
cifically, and reversibly regulating neuronal activity. This should 
empower efforts to unravel the circuitry controlling feeding and 
its related behaviors. Here, we found that AgRP neuron activity 
is both necessary and sufficient for feeding — inhibition of AgRP 
neurons at a time when mice normally eat (at the beginning of the 
dark cycle) restrains feeding, while stimulation of AgRP neurons 
when mice are nutritionally replete (near the beginning of the light 
cycle) compels feeding. Furthermore, we demonstrate that these 
same neurons drive not only a behavioral program to consume 
food, but to seek it out as well.
Methods
An expanded Methods section is provided in Supplemental Methods.
Animals. All animal care and experimental procedures were approved 
by the Beth Israel Deaconess Medical Center Institutional Animal Care 
and Use Committee. Mice from a mixed background (129/C57BL6) were 
housed at 22°C–24°C with a 12-hour light/12-hour dark cycle with stan-
dard mouse chow and water provided ad libitum. AgRP-Ires-cre mice have 
been previously described (4).
Generation of AAV-hM3Dq-mCherry and AAV-hM4Di-mCherry vectors. The 
hM3Dq and hM4Di coding sequences were cloned into a mCherry vector 
(18) upstream of the mCherry sequence to generate C-terminal mCherry 
fusion proteins. The hM3Dq-mCherry and hM4Di-mCherry coding 
sequences were amplified by PCR, and the amplicons and a cre-inducible 
AAV vector with a human Synapsin 1 promoter (refs. 19 and 20; a gift from 
Karl Deisseroth, Howard Hughes Medical Institute, Department of Bio-
engineering and Department of Psychiatry and Behavioral Sciences, Stan-
ford University, Stanford, California, USA.) were digested with NheI and 
AscI. The digestion products were ligated such that the coding regions for 
the fusion proteins were in a 3′ to 5′ orientation relative to the promoter. 
The final vectors were sequence verified and packaged in serotype 8.
Stereotaxic AAV-DREADD-mCherry injections. Mice were injected as pre-
viously described (21). Briefly, 200-nL bilateral injections were made in 
the ARC of AgRP-Ires-cre and wild-type littermate controls (coordinates, 
Figure 3
Stimulating AgRP neurons drives a behavioral program to work for and search for food. (A) Ad lib–fed animals injected with saline were first 
trained to associate a successful nose poke with a reward pellet using an FR1 schedule. Following the training period, the same cohort was 
injected with CNO (0.3 mg/kg of body weight, i.p.) or saline and then tested on a PR3. Acute stimulation of AgRP neurons in mice fed ad lib led to 
a significant increase in the break point, similar to the break point observed in fasted mice. Data shown are from male mice (mean ± SEM, n = 6, 
*P < 0.01). (B) Stimulation of AgRP neurons increases physical activity when food is absent but not when food is present. In the food-absent 
study, food was removed immediately following CNO or saline injection. The number of ambulatory episodes along the horizontal plane was 
assessed 0–1 hour, 1–2 hours, 2–3 hours, 3–4 hours, and 4–5 hours PI. The same cohort of mice was used in the food – and food + studies. 
Data shown are from male mice (mean ± SEM, n = 4, *P < 0.01).
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bregma: anterior-posterior, –1.40 mm; dorsal-ventral, –5.80 mm; lateral, 
+/–0.30 mm). Mice were allowed 1 week to recover and then acclimated to 
handling for 1 week before the start of any in vivo studies.
Immunohistochemistry. Immunohistochemistry was performed as previ-
ously described (22). The primary antibodies used in these studies include 
rabbit anti-dsRed (Clontech; 1:2,500), chicken anti-GFP (Abcam; 1:1000), 
and rabbit anti–c-fos (Calbiochem; 1:25,000).
Electrophysiology. The protocols of slice preparation and whole cell record-
ing are previously described (22). 5- to 7-week-old mice injected with AAV 
10–14 days previously were used. After acquisition of stable whole cell 
recordings on AgRP neurons for 2–5 minutes, artificial cerebral spinal fluid 
solution containing 5–10 μM CNO was perfused.
Food intake studies. Food intake studies on chow were performed as previ-
ously described (4). Food intake was assessed at different time points fol-
lowing injection of either saline or CNO (0.3 mg/kg) on alternating days in 
the acute studies (data shown is from male mice) or 5 days straight in the 
chronic studies (data shown is from female mice). Body composition (fat 
mass) was analyzed as previously described (4) using EchoMRI.
Energy expenditure measurements. Energy expenditure was assessed by mea-
suring oxygen consumption as previously described (4) using a compre-
hensive lab animal monitoring system (CLAMS; Columbus Instruments). 
Data reported here are from male mice.
Nose poke assay. Operant conditioning sessions were conducted as pre-
viously described (16). Briefly, for 5 consecutive days mice fed ad libi-
tum were injected i.p. with saline, placed in chambers, and acclimated 
to nose poking for food pellets for a period of 60 minutes under an FR1 
operant paradigm.
Following completion of FR1 training, mice fed ad libitum were then 
exposed to a PR3 testing paradigm (60-minute duration) for the follow-
ing 6 days and were treated with saline or CNO (0.3 mg/kg) on alternate 
days. Data are presented as the breakpoint during the PR3. Following the 
completion of drug treatments, mice were fasted for 24 hours and then 
tested again under PR3 conditions immediately following injection with 
saline. Data reported herein are from male mice.
Beam-break assay. Locomotor activity was assessed as previously described 
(17). Briefly, individually housed mice were placed in their home cages, and 
ambulatory counts along the x axis were recorded for 5 hours during the 
light cycle either in the absence or presence of food. Data reported herein 
are from male mice.
Statistics. Statistical analyses were performed using KaleidaGraph (Syn-
ergy Software). Overall ANOVA analyses were followed by planned pairwise 
comparisons between the relevant groups with a Tukey’s honestly signifi-
cant difference post-hoc test. A P value of less than 0.05 was considered 
significant in these studies.
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